• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

相似文献

1
Biological effect of lead-212 localized in the nucleus of mammalian cells: role of recoil energy in the radiotoxicity of internal alpha-particle emitters.定位在哺乳动物细胞核中的铅-212的生物学效应:反冲能量在内部α粒子发射体放射毒性中的作用。
Radiat Res. 1994 Nov;140(2):276-83.
2
Relative biological effectiveness of alpha-particle emitters in vivo at low doses.低剂量下体内α粒子发射体的相对生物学效应
Radiat Res. 1994 Mar;137(3):352-60.
3
On the dose calculation at the cellular level and its implications for the RBE of (99m)Tc and ¹²³I.关于细胞水平的剂量计算及其对(99m)Tc和¹²³I的相对生物效应的影响。
Med Phys. 2014 Jun;41(6):062503. doi: 10.1118/1.4876296.
4
Radiotoxicity of gadolinium-148 and radium-223 in mouse testes: relative biological effectiveness of alpha-particle emitters in vivo.钆-148和镭-223对小鼠睾丸的辐射毒性:体内α粒子发射体的相对生物效能
Radiat Res. 1997 Mar;147(3):342-8.
5
Pb Theranostic Radiopharmaceuticals for Image-guided Radionuclide Therapy for Cancer.用于癌症导向放射性核素治疗的放射性诊断和治疗药剂。
Curr Med Chem. 2020;27(41):7003-7031. doi: 10.2174/0929867327999200727190423.
6
The question of relative biological effectiveness and quality factor for auger emitters incorporated into proliferating mammalian cells.纳入增殖哺乳动物细胞中的俄歇电子发射体的相对生物有效性和品质因数问题。
Radiat Res. 1991 Dec;128(3):282-92.
7
Radiotoxicity of platinum-195m-labeled trans-platinum (II) in mammalian cells.195m铂标记反式铂(II)在哺乳动物细胞中的放射毒性。
Radiat Res. 1994 Oct;140(1):55-62.
8
Cellular dosimetry: absorbed fractions for monoenergetic electron and alpha particle sources and S-values for radionuclides uniformly distributed in different cell compartments.细胞剂量学:单能电子和α粒子源的吸收分数以及放射性核素在不同细胞区室中均匀分布的S值。
J Nucl Med. 1994 Feb;35(2):303-16.
9
Variation in RBE for Survival of V79-4 Cells as a Function of Alpha-Particle (Helium Ion) Energy.V79-4细胞存活的相对生物学效应随α粒子(氦离子)能量的变化。
Radiat Res. 2015 Jul;184(1):33-45. doi: 10.1667/RR13835.1. Epub 2015 Jun 29.
10
Radiotoxicity of an 125I-labeled DNA intercalator in mammalian cells.一种¹²⁵I标记的DNA嵌入剂在哺乳动物细胞中的放射毒性。
Radiat Res. 1989 May;118(2):283-94.

引用本文的文献

1
Factors Influencing the Therapeutic Efficacy of the PSMA Targeting Radioligand Pb-NG001.影响PSMA靶向放射性配体Pb-NG001治疗效果的因素
Cancers (Basel). 2022 Jun 3;14(11):2784. doi: 10.3390/cancers14112784.
2
Pb-conjugated anti-rat HER2/ antibody against a -N derived murine mammary carcinoma cell line: cell kill and RBE in vitro.Pb 偶联的抗鼠 HER2/ 抗体对 -N 衍生的鼠乳腺癌细胞系的杀伤作用及体外 RBE。
Int J Radiat Biol. 2022;98(9):1452-1461. doi: 10.1080/09553002.2022.2033341. Epub 2022 Feb 9.
3
Evolution of Neuroendocrine Tumor Therapy.神经内分泌肿瘤治疗的演进。
Surg Oncol Clin N Am. 2020 Apr;29(2):145-163. doi: 10.1016/j.soc.2019.11.002.
4
Targeting PARP-1 with Alpha-Particles Is Potently Cytotoxic to Human Neuroblastoma in Preclinical Models.靶向 PARP-1 的 Alpha 粒子在临床前模型中对人类神经母细胞瘤具有强大的细胞毒性。
Mol Cancer Ther. 2019 Jul;18(7):1195-1204. doi: 10.1158/1535-7163.MCT-18-0837. Epub 2019 May 9.
5
Modeling Cell and Tumor-Metastasis Dosimetry with the Particle and Heavy Ion Transport Code System (PHITS) Software for Targeted Alpha-Particle Radionuclide Therapy.利用粒子和重离子输运代码系统(PHITS)软件对靶向α粒子放射性核素治疗进行细胞和肿瘤转移剂量学建模。
Radiat Res. 2018 Sep;190(3):236-247. doi: 10.1667/RR15081.1. Epub 2018 Jun 26.
6
Cell Killing Mechanisms and Impact on Gene Expression by Gemcitabine and 212Pb-Trastuzumab Treatment in a Disseminated i.p. Tumor Model.吉西他滨和212Pb-曲妥珠单抗治疗对播散性腹腔肿瘤模型的细胞杀伤机制及基因表达的影响
PLoS One. 2016 Jul 28;11(7):e0159904. doi: 10.1371/journal.pone.0159904. eCollection 2016.
7
Survival of tumor and normal cells upon targeting with electron-emitting radionuclides.用发射电子的放射性核素对肿瘤和正常细胞进行靶向治疗后的存活情况。
Med Phys. 2013 Jan;40(1):014101. doi: 10.1118/1.4769409.
8
Monte Carlo simulation of irradiation and killing in three-dimensional cell populations with lognormal cellular uptake of radioactivity.放射性活度对数正态细胞摄取的三维细胞群体的辐照和杀伤的蒙特卡罗模拟。
Int J Radiat Biol. 2012 Jan;88(1-2):115-22. doi: 10.3109/09553002.2011.602379. Epub 2011 Nov 30.
9
Towards translation of 212Pb as a clinical therapeutic; getting the lead in!迈向 212Pb 作为临床治疗剂的转化;引领潮流!
Dalton Trans. 2011 Jun 21;40(23):6068-76. doi: 10.1039/c0dt01387k. Epub 2011 Mar 4.
10
Targeted alpha-therapy: past, present, future?靶向α治疗:过去、现在与未来?
Dalton Trans. 2007 Nov 21(43):4918-28. doi: 10.1039/b704726f. Epub 2007 Sep 11.

本文引用的文献

1
Effects of different ionizing radiations on human cells in tissue culture. III. Experiments with cyclotron-accelerated alpha-particles and deuterons.不同电离辐射对组织培养中人体细胞的影响。III. 回旋加速器加速的α粒子和氘核实验。
Radiat Res. 1963 Jan;18:106-19.
2
Cellular dosimetry: absorbed fractions for monoenergetic electron and alpha particle sources and S-values for radionuclides uniformly distributed in different cell compartments.细胞剂量学:单能电子和α粒子源的吸收分数以及放射性核素在不同细胞区室中均匀分布的S值。
J Nucl Med. 1994 Feb;35(2):303-16.
3
Relative biological effectiveness of alpha-particle emitters in vivo at low doses.低剂量下体内α粒子发射体的相对生物学效应
Radiat Res. 1994 Mar;137(3):352-60.
4
Radiotoxicity of 75Se and 35S: theory and application to a cellular model.
Radiat Res. 1980 Dec;84(3):407-25.
5
A rapid and reproducible method for the separation of cells from radioactive media.
J Nucl Med. 1980 Jan;21(1):88-90.
6
Intracellular distribution and radiotoxicity of chromium-51 in mammalian cells: Auger-electron dosimetry.
J Nucl Med. 1985 Jan;26(1):59-67.
7
The in vitro radiobiology of astatine-211 decay.砹-211衰变的体外放射生物学
Radiat Res. 1986 Jan;105(1):27-36.
8
212Bismuth linked to an antipancreatic carcinoma antibody: model for alpha-particle-emitter radioimmunotherapy.
J Natl Cancer Inst. 1988 May 18;80(6):449-52. doi: 10.1093/jnci/80.6.449.
9
RBE for deterministic effects. A report of a Task Group of Committee I of the International Commission on Radiological protection.
Ann ICRP. 1989;20(4):1-57.
10
In-vivo radiotoxicity of DNA-incorporated 125I compared with that of densely ionising alpha-particles.与密集电离的α粒子相比,掺入DNA的125I的体内放射毒性。
Lancet. 1989 Sep 16;2(8664):650-3. doi: 10.1016/s0140-6736(89)90896-9.

定位在哺乳动物细胞核中的铅-212的生物学效应:反冲能量在内部α粒子发射体放射毒性中的作用。

Biological effect of lead-212 localized in the nucleus of mammalian cells: role of recoil energy in the radiotoxicity of internal alpha-particle emitters.

作者信息

Azure M T, Archer R D, Sastry K S, Rao D V, Howell R W

机构信息

Department of Radiology, University of Medicine & Dentistry of New Jersey, New Jersey Medical School, Newark 07103.

出版信息

Radiat Res. 1994 Nov;140(2):276-83.

PMID:7938477
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC3321059/
Abstract

The radiochemical dipyrrolidinedithiocarbamato-212Pb(II) [212Pb(PDC)2] is synthesized and its effects on colony formation in cultured Chinese hamster V79 cells are investigated. The cellular uptake, biological retention, subcellular distribution and cytotoxicity of the radiocompound are determined. The 212Pb is taken up quickly by the cells, reaching saturation levels in 1.25 h. When the cells are washed, the intracellular activity is retained with a biological half-life of 11.6 h. Gamma-ray spectroscopy indicates that the 212Pb daughters (212Bi, 212Po and 208Tl) are in secular equilibrium within the cell. About 72% of the cellular activity localizes in the cell nucleus, of which 35% is bound specifically to nuclear DNA. The mean cellular uptake required to achieve 37% survival is 0.35 mBq of 212Pb per cell, which delivers a dose of 1.0 Gy to the cell nucleus when the recoil energy of 212Bi and 212Po decays is ignored and 1.7 Gy when recoil is included. The corresponding RBE values compared to acute external 137Cs gamma rays at 37% survival are 4.0 and 2.3, respectively. The chemical Pb(PDC)2 is not chemotoxic at the concentrations used in this study. Because the beta-particle emitter 212Pb decays to the alpha-particle-emitting daughters 212Bi and 212Po, these studies provide information on the biological effects of alpha-particle decays that occur in the cell nucleus. Our earlier studies with cells of the same cell line using 210Po (emits 5.3 MeV alpha particle) localized predominantly in the cytoplasm resulted in an RBE of 6. These earlier results for 210Po, along with the present results for 212Pb, suggest that the recoil energy associated with the 212Bi and 212Po daughter nuclei plays little or no role in imparting biological damage to critical targets in the cell nucleus.

摘要

合成了放射化学物质二吡咯烷基二硫代氨基甲酸 - 212Pb(II) [212Pb(PDC)2],并研究了其对培养的中国仓鼠V79细胞集落形成的影响。测定了该放射性化合物的细胞摄取、生物滞留、亚细胞分布和细胞毒性。212Pb被细胞快速摄取,在1.25小时内达到饱和水平。当细胞被洗涤时,细胞内活性以11.6小时的生物半衰期保留。γ射线光谱表明212Pb的子体(212Bi、212Po和208Tl)在细胞内处于长期平衡。约72%的细胞活性定位于细胞核,其中35%特异性结合于核DNA。实现37%存活率所需的平均细胞摄取量为每细胞0.35 mBq的212Pb,当忽略212Bi和212Po衰变的反冲能量时,这会给细胞核带来1.0 Gy的剂量,当考虑反冲时为1.7 Gy。与急性外部137Cs γ射线在37%存活率时相比,相应的RBE值分别为4.0和2.3。化学物质Pb(PDC)2在本研究使用的浓度下没有化学毒性。由于β粒子发射体212Pb衰变为发射α粒子的子体212Bi和212Po,这些研究提供了关于细胞核中发生的α粒子衰变生物效应的信息。我们早期使用主要定位于细胞质的210Po(发射5.3 MeV α粒子)对同一细胞系细胞进行的研究得出的RBE为6。210Po的这些早期结果以及212Pb的当前结果表明,与212Bi和212Po子核相关的反冲能量在对细胞核中的关键靶点造成生物损伤方面作用很小或没有作用。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/fdc9/3321059/8f9f8c1abd83/nihms366340f7.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/fdc9/3321059/8222834cbf00/nihms366340f1.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/fdc9/3321059/a5e5f7160b56/nihms366340f2.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/fdc9/3321059/81b79494ca81/nihms366340f3.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/fdc9/3321059/59726ed64e2f/nihms366340f4.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/fdc9/3321059/bcc3d0be9625/nihms366340f5.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/fdc9/3321059/01962eeadcaf/nihms366340f6.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/fdc9/3321059/8f9f8c1abd83/nihms366340f7.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/fdc9/3321059/8222834cbf00/nihms366340f1.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/fdc9/3321059/a5e5f7160b56/nihms366340f2.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/fdc9/3321059/81b79494ca81/nihms366340f3.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/fdc9/3321059/59726ed64e2f/nihms366340f4.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/fdc9/3321059/bcc3d0be9625/nihms366340f5.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/fdc9/3321059/01962eeadcaf/nihms366340f6.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/fdc9/3321059/8f9f8c1abd83/nihms366340f7.jpg